Company Filing History:
1 out of 1,505 
1 out of 105 Years Active: 2017
Title: Wenying Yu: Innovator in Cancer Treatment
Introduction
Wenying Yu is a notable inventor based in Columbus, OH (US), recognized for his contributions to cancer treatment through innovative pharmaceutical compounds. His work focuses on developing inhibitors that target specific protein activities associated with uncontrolled cellular proliferation.
Latest Patents
Wenying Yu holds a patent for "STAT3 inhibitors and their anticancer use." This invention relates to substituted 6-amino-5,8-dioxo-5,8-dihydronaphthalene-1-sulfonamide analogs and derivatives, as well as substituted 4-amino-5H-naphtho[1,8-cd]isothiazol-5-one 1,1-dioxide analogs. These compounds are designed to inhibit STAT protein activity, providing potential therapeutic applications for treating disorders linked to STAT protein dysfunction. The patent also includes synthetic methods for creating these compounds and pharmaceutical compositions that incorporate them.
Career Highlights
Throughout his career, Wenying Yu has been associated with prominent institutions such as the Ohio State Innovation Foundation and the Research Institute at Nationwide Children's Hospital. His work in these organizations has significantly contributed to advancements in medical research and innovation.
Collaborations
Wenying Yu has collaborated with esteemed colleagues, including Chenglong Li and Jiayuh Lin, who have played vital roles in his research endeavors.
Conclusion
Wenying Yu's innovative work in developing STAT3 inhibitors showcases his commitment to advancing cancer treatment. His contributions to the field highlight the importance of research and collaboration in the pursuit of effective medical solutions.